Efficient generation of TBX3+ atrioventricular conduction-like cardiomyocytes from human pluripotent stem cells

Biochem Biophys Res Commun. 2023 Aug 20:669:143-149. doi: 10.1016/j.bbrc.2023.05.104. Epub 2023 May 26.

Abstract

Atrioventricular conduction cardiomyocytes (AVCCs) regulate the rate and rhythm of heart contractions. Dysfunction due to aging or disease can cause atrioventricular (AV) block, interrupting electrical impulses from the atria to the ventricles. Generation of functional atrioventricular conduction like cardiomyocytes (AVCLCs) from human pluripotent stem cells (hPSCs) provides a promising approach to repair damaged atrioventricular conduction tissue by cell transplantation. In this study, we put forward the generation of AVCLCs from hPSCs by stage-specific manipulation of the retinoic acid (RA), WNT, and bone morphogenetic protein (BMP) signaling pathways. These cells express AVCC-specific markers, including the transcription factors TBX3, MSX2 and NKX2.5, display functional electrophysiological characteristics and present low conduction velocity (0.07 ± 0.02 m/s). Our findings provide new insights into the understanding of the development of the atrioventricular conduction system and propose a strategy for the treatment of severe atrioventricular conduction block by cell transplantation in future.

Keywords: Atrioventricular conduction cardiomyocytes; Human pluripotent stem cell; MSX2; NKX2.5; TBX3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrioventricular Block*
  • Heart Conduction System / metabolism
  • Humans
  • Myocytes, Cardiac / metabolism
  • Pluripotent Stem Cells* / metabolism
  • T-Box Domain Proteins / metabolism
  • Transcription Factors / metabolism

Substances

  • T-Box Domain Proteins
  • Transcription Factors
  • TBX3 protein, human